Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109418 · ClinicalTrials.gov registry record · Phase 2
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT03109418 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants.
The verdict
NCT03109418, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The aim of this study is to substantially reduce overall postoperative morbidity and mortality associated with obstructive sleep apnea.
Interventions
- PROCEDURE Control
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-06-02 |
| Est. Completion | 2018-09-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03109418
The ClinicalTrials.gov registry entry for NCT03109418 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03109418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03109418 about?
NCT03109418 is a clinical study titled "Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea". The aim of this study is to substantially reduce overall postoperative morbidity and mortality associated with obstructive sleep apnea.
What is the current status of trial NCT03109418?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2016-06-02. Estimated completion is 2018-09-12.
What interventions are being tested in trial NCT03109418?
The interventions under investigation include: Control (PROCEDURE), Ketamine (DRUG).
Who is sponsoring clinical trial NCT03109418?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.